MERLINO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 7.415
AS - Asia 4.365
EU - Europa 2.301
SA - Sud America 771
Continente sconosciuto - Info sul continente non disponibili 377
AF - Africa 102
OC - Oceania 7
Totale 15.338
Nazione #
US - Stati Uniti d'America 7.219
SG - Singapore 2.302
CN - Cina 744
BR - Brasile 569
IT - Italia 547
UA - Ucraina 440
HK - Hong Kong 365
VN - Vietnam 336
DE - Germania 285
FI - Finlandia 211
RU - Federazione Russa 198
FR - Francia 193
BD - Bangladesh 183
CA - Canada 96
GB - Regno Unito 89
IE - Irlanda 86
AR - Argentina 73
KR - Corea 66
IN - India 65
SE - Svezia 48
NL - Olanda 43
IQ - Iraq 42
TR - Turchia 40
ID - Indonesia 39
ZA - Sudafrica 36
EC - Ecuador 32
MX - Messico 32
CO - Colombia 29
PL - Polonia 29
AT - Austria 27
PK - Pakistan 27
JP - Giappone 25
ES - Italia 22
VE - Venezuela 22
UZ - Uzbekistan 19
SA - Arabia Saudita 17
PY - Paraguay 16
BE - Belgio 15
CR - Costa Rica 14
PH - Filippine 14
MA - Marocco 13
CL - Cile 12
IR - Iran 12
TG - Togo 11
EG - Egitto 10
LT - Lituania 10
MY - Malesia 10
EU - Europa 9
HN - Honduras 9
JM - Giamaica 9
PE - Perù 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
TT - Trinidad e Tobago 8
AM - Armenia 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
DZ - Algeria 5
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
BH - Bahrain 4
BS - Bahamas 4
EE - Estonia 4
GT - Guatemala 4
KG - Kirghizistan 4
RO - Romania 4
TN - Tunisia 4
BO - Bolivia 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
NI - Nicaragua 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BZ - Belize 2
DK - Danimarca 2
GA - Gabon 2
KH - Cambogia 2
LI - Liechtenstein 2
LU - Lussemburgo 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
Totale 14.944
Città #
Singapore 859
Ashburn 802
San Jose 556
Fairfield 463
Woodbridge 462
Ann Arbor 386
Hong Kong 351
Beijing 333
Council Bluffs 321
Jacksonville 313
Houston 312
Chandler 284
Wilmington 204
Cambridge 167
Dearborn 165
Boardman 161
Seattle 154
Los Angeles 132
Lauterbourg 129
Ho Chi Minh City 108
Princeton 91
New York 85
Dallas 84
Dublin 83
São Paulo 83
Santa Clara 78
Hanoi 71
Buffalo 64
Hefei 62
Seoul 62
Milan 57
Helsinki 51
Redondo Beach 47
Munich 40
Frankfurt am Main 37
Rome 35
Phoenix 33
San Diego 33
Orem 31
Trieste 31
Udine 29
Atlanta 28
Ogden 28
Izmir 27
Chicago 26
Venezia 26
Norwalk 25
Tavagnacco 25
The Dalles 25
Warsaw 24
Johannesburg 23
Nuremberg 23
Denver 22
Guangzhou 22
Tokyo 21
Toronto 21
Dong Ket 20
Ottawa 20
Brooklyn 19
Montreal 19
Buenos Aires 18
London 18
Rio de Janeiro 17
Stockholm 17
Amsterdam 16
Boston 16
Des Moines 16
Tashkent 16
Brasília 14
Da Nang 14
Düsseldorf 14
San Francisco 14
Brussels 13
Codroipo 13
Mexico City 13
Shanghai 13
Haiphong 12
Mumbai 12
Naples 12
Vienna 12
Florence 11
Lomé 11
Nanjing 11
Quito 11
San José 11
Washington 11
Baghdad 10
Kunming 10
Lappeenranta 10
Poplar 10
Bogotá 9
Bologna 9
Hyderabad 9
Lahore 9
Newark 9
North Bergen 9
Philadelphia 9
San Pietro Mussolino 9
Asunción 8
Biên Hòa 8
Totale 8.777
Nome #
Restless legs syndrome: diagnosis, epidemiology, classification and consequences. 272
Restless legs syndrome: differential diagnosis and management with rotigotine 265
Clinical experience with pramipexole in the treatment of restless legs syndrome 200
ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome 195
Gabapentin Enacarbil in Restless Legs Syndrome 185
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure 181
Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures 176
ADMET considerations for restless leg syndrome drug treatments. 172
The use of rotigotine in the treatment of restless legs syndrome. 172
Association of body rolling, leg rolling, and rhythmic feet movements in a young adult: A video-polysomnographic study performed before and after one night of clonazepam. 167
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 164
Anticholinergic drugs and neuropsychiatry symptoms in Alzheimer’s disease 162
Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study. 160
Are sleep disorders able to increase cardiovascular risk in continuous ambulatory peritoneal dialysis (CAPD) patients ? 160
Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects 159
La sindrome delle gambe senza riposo nel paziente nefropatico 158
The Acute Effect of a Low Dosage of Pramipexole on Severe Idiopathic Restless Legs Syndrome: An Open-Label Trial. 156
Timing use of novel anti-epileptic drugs: is earlier better? 154
Lacosamide for the treatment of epilepsy 152
Are sleep disorders able to Increase cardiovascular risk in chronic hemodialyzed patients (CHP) ? 150
Efficacy and Safety of Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and Pre⁻Existing Disability 150
Impact of atrial fibrillation on outcomes in stroke patients with tandem occlusions treated with thrombectomy: A multicentre study 148
Investigational approaches to therapies for restless legs syndrome 148
Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review 147
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. 147
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease 147
Pharmacotherapy of restless legs syndrome with pramipexole 146
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 143
Association between Restless Legs Syndrome and type 2 diabetes: a case control study. 142
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 141
Age-Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 138
The Prepetrous Segment of the Internal Carotid Artery as a Neglected Site of Symptomatic Atherosclerosis: A Single-Center Series 138
Daytime Sleepiness is Associated with Dementia and Cognitive Decline in Older Italian Adults. A population-based study 136
Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 135
Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis 134
Brady Arrhythmia and sinus arrest in REM sleep 132
Seizures with prolonged EEG abnormalities during an attack of migraine without aura. 128
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient 125
Anti-neuropil antibodies in a patient with limbic encephalitis and breast cancer 124
Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports 122
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 121
­ Motor patterns of alien limb in different vigilance states: recording of periodic limb movement during wakefulness vs. sleep in a patient with Corticobasal degeneration (CBD) 121
Bereitshaftpotential and fatigue in recently diagnosed SM patients 120
Sleep-related movement disorders. 119
2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study 118
Prevalence of “poor sleep” among patients with multiple sclerosis: An independent predictor of mental and physical status 118
Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: "Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico") 118
Prevalence and impact on quality of life of sleep disturbance among patients affected by multiple sclerosis. 117
Association between restless legs Syndrome and type 2 diabetes and consequences on quality of life and on psychological status: a case-control study 117
­Sleep fragmentation and cerebrovascular risk factors 117
Sensory gating deficit assessed by the P50 midlatency auditory evoked potential in untreated patients with Alzheimer’s Disease (AD): correlation with NeuroPsychiatric Symptoms (NPS) and modifications induced by the Cholinesterase Inhibitor (CHEI) done 117
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 116
Response to restless legs syndrome and diabetic neuropathy--commentary by Gemignani, et al 116
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 114
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 114
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 113
Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer’s disease 112
Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study 112
Event – Related Potential ERP) P300 in chronic vascular hemiparetic patients 111
The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review 110
Prevalence of sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 110
­Alternating leg muscle activation (ALMA) with excessive daytime sleepiness 110
Restless legs syndrome in chronic hemodyalized patients: preliminary data 110
Ketogenic diet may improve sleep quality and daytime somnolence in patients affected by multiple sclerosis. Results of an exploratory study 108
­Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 108
The effect of drugs with anticholinergic activity on cognitive and neuropsychiatric symptoms in Alzheimer disease 108
Do sleep disorders start in dialysis or in early chronic kidney disease? Reply 106
Seizures after ischemic stroke: a matched multicenter study 106
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment 105
Sleep paralysis and hallucinations 104
Seizures Do Not Affect Disability and Mortality Outcomes of Stroke: A Population-Based Study 104
­Effetti acuti di basse dosi di pramipexolo in pazienti affetti da Sindrome delle gambe senza riposo severa idiopatica 103
­ Prevalence of “poor sleep” among patients with multiple sclerosis: an independent predictor of mental and physical status 103
When Nothing Goes Right: An Unexpected Tongue Deviation in Internal Carotid Artery Dissection 103
Ketogenic Diet Improves Sleep Quality and Daytime Sleepiness in Chronic Migraine: A Pilot Study 102
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 101
. Ottimizzazione della terapia farmacologia con pregabalin in un paziente con epilessia ed alterazioni del sonno notturno (sindrome delle gambe senza riposo) 101
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 100
Recanalisation theraphy for acute ischemic stroke in cancer patients 100
­Patologie ipofisarie e sonno 99
Trattamento farmacologico della sindrome delle gambe senza riposo con farmaci non-dopaminoagonisti 98
Sleep disturbances in dialysis patients 97
Effects of restless legs syndrome on quality of life ad psychological status in patients with type 2 diabetes 97
Stress Hyperglycemia in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion Undergoing Mechanical Thrombectomy 96
­Disturbi del sonno in pazienti affetti da insufficienza renale cronica sottoposti a terapia dialitica 95
To Treat or Not to Treat: Importance of Functional Dependence in Deciding Intravenous Thrombolysis of "Mild Stroke" Patients 95
The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling 95
­The predictive value of mini-mental state examination as dementia screening tool in general medical practice 94
Prior Use of Antiplatelet Therapy and Outcomes after Endovascular Therapy in Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single-Center Experience 94
­Sindrome delle gambe senza riposo: tra certezze e controversie 93
Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis 93
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke 92
La sindrome delle gambe senza riposo nei pazienti emodializzati cronici 92
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome 92
Neuroinvasive west nile infection with an unusual clinical presentation: a single-center case series 92
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves: A Meta-Analysis 91
Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study 91
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 90
Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation 89
­Event-Related Potential (ERP) P300 in chronic vascular hemiparetic patients 88
Totale 12.607
Categoria #
all - tutte 59.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022519 0 0 0 46 15 46 18 41 9 103 133 108
2022/2023696 97 39 17 74 74 207 3 44 70 7 30 34
2023/2024395 38 22 31 10 27 36 7 40 44 71 9 60
2024/20252.906 40 138 110 99 221 126 140 130 311 238 561 792
2025/20265.259 397 462 464 555 729 353 522 219 333 457 473 295
2026/20271.587 195 312 514 566 0 0 0 0 0 0 0 0
Totale 15.338